Contact

All Stories

  1. Semi-Quantitative Ultrasonographic Evaluation of NAFLD

    Article • Current Pharmaceutical Design, September 2020, Bentham Science Publishers

    Claudio Tana, Professor Amedeo LONARDO

  2. History of Nonalcoholic Fatty Liver Disease

    Article • International Journal of Molecular Sciences, August 2020, MDPI AG

    Professor Amedeo LONARDO

  3. NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management

    Article • International Journal of Molecular Sciences, June 2019, MDPI AG

    Professor Amedeo LONARDO

  4. A critical appraisal of the use of ultrasound in hepatic steatosis

    Article • Expert Review of Gastroenterology & Hepatology, May 2019, Taylor & Francis

    Professor Amedeo LONARDO, Dr Giampiero Francica, stefano ballestri

  5. Telomere shortening: An innocent bystander at the crossroad of NASH with ageing and cardiometabolic risk?

    Article • Liver International, September 2018, Wiley

    Professor Amedeo LONARDO

  6. Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?

    Article • Diseases, February 2018, MDPI AG

    Professor Amedeo LONARDO

  7. NAFLD: Is There Anything New under the Sun?

    Article • International Journal of Molecular Sciences, September 2017, MDPI AG

    Professor Amedeo LONARDO

  8. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases

    Article • Metabolism, July 2017, Elsevier

    Professor Amedeo LONARDO

  9. Nonalcoholic fatty liver disease and COPD. Are they mutually associated ?

    Article • European Respiratory Journal, June 2017, European Respiratory Society (ERS)

    Professor Amedeo LONARDO

  10. Metabolic concerns in aging HIV-infected persons

    Article • AIDS, June 2017, Wolters Kluwer Health

    Professor Amedeo LONARDO

  11. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk

    Article • Advances in Therapy, May 2017, Springer Science + Business Media

    Professor Amedeo LONARDO

  12. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

    Article • Digestive and Liver Disease, May 2017, Elsevier

    Professor Amedeo LONARDO, Dr Amalia Gastaldelli

  13. NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk

    Article • Hepatology, April 2017, Wiley

    Professor Amedeo LONARDO

  14. “ Not all forms of NAFLD were created equal ”. Do metabolic syndrome-related NAFLD and PNPLA3 -related NAFLD exert a variable impact on the risk of early carotid atherosclerosis?

    Article • Atherosclerosis, February 2017, Elsevier

    Professor Amedeo LONARDO

  15. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis

    Article • World Journal of Gastroenterology, January 2017, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Amedeo LONARDO

  16. Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy

    Article • Digestive and Liver Disease, November 2016, Elsevier

    Professor Amedeo LONARDO

  17. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

    Article • Journal of Hepatology, September 2016, Elsevier

    Professor Amedeo LONARDO

  18. Non-alcoholic fatty liver disease and risk of cardiovascular disease

    Article • Metabolism, August 2016, Elsevier

    Professor Amedeo LONARDO

  19. Alcohol and Steatosis: The Japanese Paradox

    Article • EBioMedicine, June 2016, Elsevier

    Professor Amedeo LONARDO

  20. Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes

    Article • Hepatology, May 2016, Wiley

    Professor Amedeo LONARDO

  21. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis

    Article • Journal of Gastroenterology and Hepatology, April 2016, Wiley

    Professor Amedeo LONARDO

  22. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.

    Article • Hepatology Research, March 2016, Wiley

    Professor Amedeo LONARDO

  23. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight

    Article • International Journal of Molecular Sciences, March 2016, MDPI AG

    Professor Amedeo LONARDO

  24. A “systems medicine” approach to the study of non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, March 2016, Elsevier

    Professor Amedeo LONARDO

  25. The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans

    Article • Advances in Therapy, February 2016, Springer Science + Business Media

    Professor Amedeo LONARDO

  26. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?

    Article • International Journal of Molecular Sciences, February 2016, MDPI AG

    Professor Amedeo LONARDO

  27. Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure

    Article • Medicine, February 2016, Wolters Kluwer Health

    Professor Amedeo LONARDO

  28. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease

    Article • Digestive Diseases and Sciences, January 2016, Springer Science + Business Media

    Professor Amedeo LONARDO

  29. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

    Article • World Journal of Gastroenterology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Amedeo LONARDO

  30. Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test

    Article • International Journal of Microbiology Research, January 2016, Medknow

    Professor Amedeo LONARDO

  31. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

    Article • Digestive and Liver Disease, December 2015, Elsevier

    Professor Amedeo LONARDO

  32. Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma

    Article • Journal of Clinical Virology, August 2015, Elsevier

    Professor Amedeo LONARDO

  33. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?

    Article • Endocrine, May 2015, Springer Science + Business Media

    Professor Amedeo LONARDO

  34. Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

    Article • Journal of Endocrinological Investigation, May 2015, Springer Science + Business Media

    Professor Amedeo LONARDO

  35. Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?

    Article • Liver International, May 2015, Wiley

    Professor Amedeo LONARDO

  36. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

    Article • Digestive and Liver Disease, March 2015, Elsevier

    Professor Amedeo LONARDO

  37. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

    Article • Expert Review of Gastroenterology & Hepatology, February 2015, Taylor & Francis

    Dr Giampiero Francica, Professor Amedeo LONARDO, stefano ballestri

  38. Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease

    Article • Expert Review of Gastroenterology & Hepatology, October 2014, Taylor & Francis

    Professor Amedeo LONARDO

  39. Primary lymphoma of the spleen mimicking simple benign cysts: contrast-enhanced ultrasonography and other imaging findings

    Article • Journal of Medical Ultrasonics, October 2014, Springer Science + Business Media

    Professor Amedeo LONARDO

  40. Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity?

    Article • Digestive and Liver Disease, March 2014, Elsevier

    Professor Amedeo LONARDO

  41. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

    Article • Atherosclerosis, January 2014, Elsevier

    Professor Amedeo LONARDO

  42. Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Amedeo LONARDO

  43. Nonalcoholic fatty liver disease and aging: Epidemiology to management

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Amedeo LONARDO

  44. Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Amedeo LONARDO

  45. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Amedeo LONARDO

  46. From NAFLD in clinical practice to answers from guidelines

    Article • Journal of Hepatology, October 2013, Elsevier

    Professor Amedeo LONARDO

  47. Use of procalcitonin for the differential diagnosis of fever in cancer patients: an observational study

    Article • Italian Journal of Medicine, September 2013, PAGEPress Publications

    Professor Amedeo LONARDO

  48. Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD)

    Article • Clinics and Research in Hepatology and Gastroenterology, September 2013, Elsevier

    Professor Amedeo LONARDO

  49. Relationship of Serum Fetuin-A Levels with Coronary Atherosclerotic Burden and NAFLD in Patients Undergoing Elective Coronary Angiography

    Article • Metabolic Syndrome and Related Disorders, August 2013, Mary Ann Liebert Inc

    Professor Amedeo LONARDO

  50. Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD

    Article • Current Pharmaceutical Design, July 2013, Bentham Science Publishers

    Professor Amedeo LONARDO

  51. HCV treatment in patients with metabolic syndrome

    Article • May 2013, Future Medicine

    Professor Amedeo LONARDO

  52. Liver and diabetes. A vicious circle

    Article • Hepatology Research, January 2013, Wiley

    Professor Amedeo LONARDO

  53. Potential for statins in the chemoprevention and management of hepatocellular carcinoma

    Article • Journal of Gastroenterology and Hepatology, October 2012, Wiley

    Professor Amedeo LONARDO

  54. Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis

    Article • Hepatology Research, August 2012, Wiley

    Professor Amedeo LONARDO

  55. If steatosis is the atherosclerosis of the liver, are statins the “aspirin” for steatosis?

    Article • Digestive and Liver Disease, June 2012, Elsevier

    Professor Amedeo LONARDO

  56. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD

    Article • Liver International, April 2012, Wiley

    Professor Amedeo LONARDO

  57. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis

    Article • Atherosclerosis, April 2012, Elsevier

    Professor Amedeo LONARDO

  58. Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease

    Article • Archives of Medical Research, November 2011, Elsevier

    Professor Amedeo LONARDO

  59. Metabolic alterations and chronic hepatitis C: treatment strategies

    Article • Expert Opinion on Pharmacotherapy, September 2011, Informa Healthcare

    Professor Amedeo LONARDO

  60. Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk?

    Article • Archives of Medical Research, July 2011, Elsevier

    Professor Amedeo LONARDO

  61. Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: What do they mean and do they agree?

    Article • Hepatology, May 2011, Wiley

    Professor Amedeo LONARDO

  62. Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?

    Article • Internal and Emergency Medicine, May 2011, Springer Science + Business Media

    Professor Amedeo LONARDO

  63. Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?

    Article • Expert Review of Gastroenterology & Hepatology, April 2011, Taylor & Francis

    Professor Amedeo LONARDO

  64. Perspectives on cellular dysfunction in nonalcoholic steatohepatitis: a case of ‘multiorganelle failure’? Proceedings of a virtual workshop on nonalcoholic steatohepatitis

    Article • Expert Review of Gastroenterology & Hepatology, April 2011, Taylor & Francis

    Professor Amedeo LONARDO

  65. Clinical physiology of NAFLD: a critical overview of pathogenesis and treatment

    Article • Expert Review of Endocrinology & Metabolism, May 2010, Taylor & Francis

    Professor Amedeo LONARDO

  66. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

    Article • Digestive and Liver Disease, April 2010, Elsevier

    Professor Amedeo LONARDO

  67. Nonalcoholic Fatty Liver Disease in HIV-Infected Persons: Epidemiology and the Role of Nucleoside Reverse Transcriptase Inhibitors

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2010, Wolters Kluwer Health

    Professor Amedeo LONARDO

  68. Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6−174G/C polymorphism is associated with non-alcoholic steatohepatitis

    Article • Digestive and Liver Disease, November 2009, Elsevier

    Professor Amedeo LONARDO

  69. NAFLD and Cardiovascular Risk: Direct Evidence for the Tale of Two Ages

    Article • The American Journal of Gastroenterology, July 2009, Springer Science + Business Media

    Professor Amedeo LONARDO

  70. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

    Article • Journal of Gastroenterology and Hepatology, May 2009, Wiley

    Professor Amedeo LONARDO

  71. Endocrine and liver interaction: the role of endocrine pathways in NASH

    Article • Nature Reviews Gastroenterology & Hepatology, April 2009, Springer Science + Business Media

    Professor Amedeo LONARDO

  72. Hepatitis C and diabetes: the inevitable coincidence?

    Article • Expert Review of Anti-infective Therapy, April 2009, Taylor & Francis

    Professor Amedeo LONARDO

  73. Fatty Liver and Carotid Intimal Thickening: A Tale of Two Ages?

    Article • The American Journal of Gastroenterology, March 2009, Springer Science + Business Media

    Professor Amedeo LONARDO

  74. Hepatitis C Virus-Infected Patients Are ‘Spared’ from the Metabolic Syndrome but Not from Insulin Resistance. A Comparative Study of Nonalcoholic Fatty Liver Disease and Hepatitis C Virus-Related Steatosis

    Article • Canadian Journal of Gastroenterology, January 2009, Hindawi Publishing Corporation

    Professor Amedeo LONARDO

  75. The hepatitis C virus-associated dysmetabolic syndrome

    Article • Hepatology, September 2008, Wiley

    Professor Amedeo LONARDO

  76. Statins in liver disease: A molehill, an iceberg, or neither?

    Article • Hepatology, August 2008, Wiley

    Professor Amedeo LONARDO

  77. Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?

    Article • Internal and Emergency Medicine, July 2008, Springer Science + Business Media

    Professor Amedeo LONARDO

  78. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis

    Article • Clinical Science, July 2008, Portland Press Ltd.

    Professor Amedeo LONARDO

  79. Dysmetabolic changes associated with HCV: a distinct syndrome?

    Article • Internal and Emergency Medicine, February 2008, Springer Science + Business Media

    Professor Amedeo LONARDO

  80. The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology

    Article • Hepatology, December 2007, Wiley

    Professor Amedeo LONARDO

  81. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question

    Article • Nutrition Metabolism and Cardiovascular Diseases, November 2007, Elsevier

    Professor Amedeo LONARDO

  82. HCV and diabetes

    Article • Digestive and Liver Disease, August 2007, Elsevier

    Professor Amedeo LONARDO

  83. Is Cholangiocarcinoma Another Complication of Insulin Resistance: A Report of Three Cases

    Article • Metabolic Syndrome and Related Disorders, June 2007, Mary Ann Liebert Inc

    Professor Amedeo LONARDO

  84. Chicken or egg turned into head or belly

    Article • Journal of Hepatology, September 2006, Elsevier

    Professor Amedeo LONARDO

  85. ‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis

    Article • Journal of Hepatology, June 2006, Elsevier

    Professor Amedeo LONARDO

  86. 17beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures

    Article • Journal of Gastroenterology and Hepatology, May 2006, Wiley

    Professor Amedeo LONARDO

  87. Hepatitis C and steatosis: a reappraisal

    Article • Journal of Viral Hepatitis, February 2006, Wiley

    Professor Amedeo LONARDO

  88. Statins and HCV: A complex issue

    Article • Hepatology, January 2006, Wiley

    Professor Amedeo LONARDO

  89. Gender, fatty liver and GGT

    Article • Hepatology, January 2006, Wiley

    Professor Amedeo LONARDO

  90. Hepatic steatosis and insulin resistance: Does etiology make a difference?

    Article • Journal of Hepatology, January 2006, Elsevier

    Professor Amedeo LONARDO

  91. Fatty liver, carotid disease and gallstones: A study of age-related associations

    Article • World Journal of Gastroenterology, January 2006, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Amedeo LONARDO

  92. Review article: hepatic steatosis and insulin resistance

    Article • Alimentary Pharmacology & Therapeutics, November 2005, Wiley

    Professor Amedeo LONARDO

  93. Review article: the metabolic syndrome and non-alcoholic fatty liver disease

    Article • Alimentary Pharmacology & Therapeutics, November 2005, Wiley

    Professor Amedeo LONARDO

  94. Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors

    Article • Journal of Gastroenterology and Hepatology, August 2005, Wiley

    Professor Amedeo LONARDO

  95. Pediatric gallstone disease in familial hypobetalipoproteinemia

    Article • Journal of Hepatology, July 2005, Elsevier

    Professor Amedeo LONARDO

  96. Should Nonalcoholic Fatty Liver Disease Be Renamed?

    Article • Digestive Diseases, January 2005, Karger Publishers

    Professor Amedeo LONARDO

  97. The wide spectrum of steatohepatitis

    Article • European Journal of Gastroenterology & Hepatology, October 2004, Wolters Kluwer Health

    Professor Amedeo LONARDO

  98. Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease

    Article • Gastroenterology, February 2004, Elsevier

    Professor Amedeo LONARDO

  99. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

    Article • Hepatology, January 2004, Wiley

    Professor Amedeo LONARDO

  100. Non-Organ-Specific Autoantibodies in Nonalcoholic Fatty Liver Disease: Prevalence and Correlates

    Article • Digestive Diseases and Sciences, November 2003, Springer Science + Business Media

    Professor Amedeo LONARDO

  101. Intestinal Wegener's granulomatosis in a patient with severe alpha-1-antitrypsin deficiency resulting from a unique combination of two deficiency alleles (PiZ and PiMProcida)

    Article • European Journal of Gastroenterology & Hepatology, December 2002, Wolters Kluwer Health

    Professor Amedeo LONARDO

  102. Apolipoprotein synthesis in nonalcoholic steatohepatitis

    Article • Hepatology, August 2002, Wiley

    Professor Amedeo LONARDO

  103. Growth hormone plasma levels in nonalcoholic fatty liver disease

    Article • The American Journal of Gastroenterology, April 2002, Springer Science + Business Media

    Professor Amedeo LONARDO

  104. Of liver, whisky and plants: a requiem for colchicine in alcoholic cirrhosis?

    Article • European Journal of Gastroenterology & Hepatology, April 2002, Wolters Kluwer Health

    Professor Amedeo LONARDO

  105. Growth hormone plasma levels in nonalcoholic fatty liver disease

    Article • The American Journal of Gastroenterology, April 2002, Wolters Kluwer Health

    Professor Amedeo LONARDO

  106. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study

    Article • Digestive and Liver Disease, March 2002, Elsevier

    Professor Amedeo LONARDO

  107. Is insulin resistance a pathogenic co-factor in hepatitis C virus-related disease and hepatocellular carcinoma?

    Article • Digestive and Liver Disease, February 2002, Elsevier

    Professor Amedeo LONARDO

  108. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5)

    Article • Journal of Hepatology, September 2000, Elsevier

    Professor Amedeo LONARDO

  109. Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution

    Article • Journal of Gastroenterology and Hepatology, July 2000, Wiley

    Professor Amedeo LONARDO

  110. Fatty Liver and Nonalcoholic Steatohepatitis. Where Do We Stand and Where Are We Going?

    Article • Digestive Diseases, January 1999, Karger Publishers

    Professor Amedeo LONARDO

  111. Isolated jejunal Crohn's disease in a young adult presenting as fever of unknown origin

    Article • The American Journal of Gastroenterology, November 1998, Springer Science + Business Media

    Professor Amedeo LONARDO

  112. Article • Digestive Diseases and Sciences, January 1998, Springer Science + Business Media

    Professor Amedeo LONARDO

  113. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B

    Article • Gastroenterology, October 1996, Elsevier

    Professor Amedeo LONARDO

  114. LETTER TO THE EDITOR

    Article • Journal of Gastroenterology and Hepatology, December 1994, Wiley

    Professor Amedeo LONARDO

  115. LETTER TO THE EDITOR

    Article • Journal of Gastroenterology and Hepatology, June 1994, Wiley

    Professor Amedeo LONARDO

  116. Are Routine Duodenal and Antral Biopsies Useful in the Management of “Functional” Dyspepsia?

    Article • Journal of Clinical Gastroenterology, September 1993, Wolters Kluwer Health

    Professor Amedeo LONARDO

  117. Right Colon Adenocarcinoma Presenting as Bacteroides fragilis Liver Abscesses

    Article • Journal of Clinical Gastroenterology, June 1992, Wolters Kluwer Health

    Professor Amedeo LONARDO

  118. Solitary Peutz-Jeghers Type Polyp of the Stomach

    Article • Endoscopy, May 1990, Thieme Publishing Group

    Professor Amedeo LONARDO

  119. Liver cirrhosis as A diabetogenic condition

    Article • Digestive Diseases and Sciences, January 1986, Springer Science + Business Media

    Dr Giampiero Francica, Professor Amedeo LONARDO

  120. Familial history in IBD

    Article • Digestive Diseases and Sciences, April 1985, Springer Science + Business Media

    Professor Amedeo LONARDO